ASCO 2023: Using Elranatamab for Myeloma Patients Previously Treated with BCMA-Directed Therapy

Press/Media

Period	Jun 20 2023

Media coverage

Title	ASCO 2023: Using Elranatamab for Myeloma Patients Previously Treated with BCMA-Directed Therapy
Media name/outlet	Myeloma Crowd
Country/Territory	United States
Date	06/20/23
URL	https://www.myelomacrowd.org/myeloma/community/articles/elranatamab-asco-2023
Persons	Asya N. Varshavsky-Yanovsky